June 17, 2026 · Form 4 insider transaction
Coastlands Capital LP bought 100,000 shares of Pasithea Therapeutics Corp. at $0.53 per share, a transaction worth $53.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.